Efalizumab (Raptiva®, Genentech) is a medication used to treat psoriasis. It is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Efalizumab".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world